2023 International Congress Archives - Page 171 of 186

Factors affecting adaptive deep brain stimulation (aDBS) indications in Parkinson’s disease

J. Tanimura (Matsumoto, Japan)
Factors influencing health-related quality of life of patients with spinocerebellar ataxia

N. Weber, M. Buchholz, A. Rädke, J. Faber, T. Schmitz-Hübsch, H. Jacobi, T. Klockgether, B. Michalowsky (Greifswald, Germany)
Factors influencing voice function after deep brain stimulation in Parkinson’s disease

H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)
Failure of model-based outcome monitoring in Parkinson’s Disease Apathy

W. Gilmour, G. Mackenzie, M. Feile, A. Macleod, V. Marshall, D. Steele, T. Gilbertson (Dundee, United Kingdom)
Falls in Mild Cognitive Impairment with Lewy bodies (MCI-LB).

E. Lirani Silva, S. Waite, C. Hamilton, P. Donaghy, J. O'Brien, J. Taylor, J. Lloyd, L. Allan, M. Firbank, A. Thomas, A. Yarnall (Newcastle, United Kingdom)
Familial Parkinson’s: Epidemiological data at Blida University Hospital.

M. Benmahdjoub, K. Kesraoui, S. Bouchetara, M. Arezki (Blida, Algeria)
Feasibility and acceptability of implementing dignity therapy as a supportive intervention for people with movement disorders.

D. Labuschagne, J. Fleisher, K. Woo, G. Fitchett (Chicago, USA)
Feasibility and efficacy of a multidisciplinary telemedicine intervention program to reduce falls and gait impairment in Parkinson’s disease (NCT04694443).

A. Garcia-Bustillo, FV. Valiñas Sieiro, A. Olivares, M. Jahouh, J. Gonzalez-Santos, M. Allende, JJ. Gonzalez-Bernal, A. Arnaiz-Gonzalez, J. Diez-Pastor, J. Trejo, JL. Garrido-Labrador, E. Cubo (Burgos, Spain)
Feasibility, Reliability and Value of Remote Levodopa Challenge Test in Parkinson’s Disease

Z. Zeng, W. Shi, X. Wan, Z. Lin, Z. Chen, C. Zhang (Shanghai, China)
Fecal tyrosine decarboxylase and motor response complications in Parkinson’s Disease

JW. Hor, SY. Lim, TS. Toh, CW. Chong, CSJ. Teh, SL. Song, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)
Feeding dystonia revealing Huntington’s disease, about a case

CH. Boukadir, S. Ouardi, N. Zemmouchi, N. Kassouri, W. Amer Elkhedoud (Ben Aknoun, Algiers, Algeria)
FGF14 repeat expansions: Case series of adult-onset cerebellar ataxia patients from Serbia

A. Milovanović, NT. Dragašević Mišković, M. Borsche, A. Westenberger, N. Brueggemann, M. Svetel, I. Petrović, VS. Kostić, K. Lohmann (Belgrade, Serbia)
Filipino’s and Parkinson’s Disease: A Scoping Review of the Literature

E. Krening, T. Seto, M. Bruno (Honolulu, USA)
Financial impact of Parkinson’s disease on women and men

C. Jiang, A. Liu, A. Ratnavel, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)
First approach of a sensor-based assessment of the camptocormia angle

K. Knutzen, K. Naderi Beni, R. Wolke, J. Kuhtz-Buschbeck, R. Rieger, NG. Margraf (Kiel, Germany)
First case of sporadic ATP6AP2 Mutation reported in Asia in a Parkinson’s Disease patient

K. Shukla, N. Sawal (Chandigarh, India)
First Case Series on the use of a High Frequency Vibrotactile Stimulation and Cueing Device in Panama

R. Rodriguez, L. Pinilla, J. Villarreal (Panama, Panama)
First Report of ERCC1-Associated Adult-Onset Hepatocellular Carcinoma, Ataxia, and Cognitive Decline

S. Radmard (Albany, USA)
Flavonoid intake and risk of Parkinson’s Disease

H. Sandoval Insausti, K. Bjornevik, J. Chavarro, M. Cortese, M. Flores, A. Hung, M. Schwarzschild, T. Yeh, A. Ascherio (Boston, USA)
Fluorescence-lifetime ophthalmoscopy findings in Parkinson’s disease patients with visual disturbances

K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)
Focused ultrasound as rescue treatment of essential tremor after deep brain stimulation.

D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. Gonzalez, S. Jaume, G. Plans, R. Alvarez (Badalona, Spain)
Foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease: subgroup analyses from a phase 3, randomized study

M. Soileau, N. Fisseha, A. Jeong, T. Kimber, K. Klos, W. Robieson, S. Talapala, E. Vaou, H. Zheng, M. Facheris, R. Hauser (Georgetown, USA)
Foslevodopa/foscarbidopa subcutaneous infusion shows similar infusion site reaction severity score across range of infusion rates in patients with Parkinson’s disease

L. Schlachter, S. Stodtmann, S. Talapala, M. Facheris, M. Rosebraugh (Ludwigshafen, Germany)
Fragile X Related Tremor in FMR1 Premutation Women without FXTAS

D. Hall, T. Svymbersky, J. O'Keefe, B. Ouyang, E. Berry-Kravis (Chicago, USA)
Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes

S. Roytman, Y. Ota, T. Brown, P. Scott, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)
Free water neuro-imaging changes as the biomarker in new diagnosis of Wilson’s disease

XP. Wang, XZ. Jing (Shanghai, China)
Free-viewing eye tracking in Parkinson’s disease and correlation with clinical features

A. Gallagher, H. Elliott, J. Inocentes, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)
Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life

R. Ou, C. Li, Q. Wei, K. Liu, J. Lin, T. Yang, Y. Xiao, Q. Jiang, Y. Cheng, Y. Hou, L. Zhang, W. Song, X. Chen, X. Lai, H. Shang (Chengdu, China)
Frequency coding mechanism of tremor in the cerebellar circuitry

MK. Pan, YM. Wang, CW. Liu, SY. Chen (Taipei, Taiwan)
Frequency of Parkinson disease following COVID-19 infection: a two-year retrospective cohort study

A. Wang, J. Perez, S. Gunzler (Cleveland, USA)
Frequency of Parkinson’s Disease in All Case Hospitalization Among Native Hawaiian/Pacific Islanders, Asian American Subgroups and Whites

M. Bruno, M. Matsunaga, E. Krening, J. Chen, G. Ross (Honolulu, USA)
Frequency of SCA 2, 3 and 7 in Slovak patients with spinocerebellar ataxia – first report of SCA2 patient from Slovakia

M. Ostrozovicova, V. Turchetti, M. Rizig, J. Necpal, V. Han, Z. Gdovinova, H. Houlden, M. Skorvanek (Kosice, Slovakia)
FRMD5 de novo variants in two cases with childhood onset ataxia and seizures

I. Keller Sarmiento, J. Blackburn, L. Mattas, M. Ruzhnikov, L. Kinsley, V. Silani, S. Lubbe, B. Bustos, D. Krainc, N. Mencacci (Chicago, USA)
From foot to head: look after your socks !

A. Riou, L. Pasquier (Rennes, France)
From the Healthy Brain Ageing – HeBA – Cohort: Motivation for participating in the first online phase of HeBA

P. Mahlknecht, T. Marques, C. Vega Moreno, C. Horlings, A. Garrido, S. Schade, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Seppi, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krueger, B. Mollenhauer, M. Marti (Innsbruck, Austria)
From the Healthy Brain Ageing (HeBA) Cohort: Frequency of key risk factors for Parkinson in a European Cohort

A. Garrido, C. Horlings, C. Vega, S. Schade, S. Ghosh, K. Rege, R. Rawal, T. Marques, P. Mahlknecht, C. Gomes, C. Pauly, D. Mcintyre, K. Seppi, MJ. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)
Functional brain network alterations in the prodromal phase of X-linked dystonia-parkinsonism

J. Steinhardt, C. Diesta, M. Heldmann, J. Dy, J. Tantianpact, H. Hanssen, R. Tuazon, R. Rosales, A. Westenberger, J. Oropilla, N. Brüggemann (Lübeck, Germany)
Functional circuit abnormalities in Levodopa-induced dyskinesia in Parkinson’s disease: A systematic review

B. Thomsen, M. Vinding, D. Meder, L. Marner, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)
Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations

S. Stampacchia, F. Bernasconi, J. Potheegadoo, J. Pagonabarraga, J. Kulisevsky, D. van Deville, E. Amico, O. Blanke (Geneve, Switzerland)
Functional movement disorders in dopa-responsive dystonia – A case series with implications for diagnosis and treatment

F. Hamami, J. Prasuhn, L. van Well, K. Lohmann, C. Klein, N. Brüggemann, T. Bäumer, A. Münchau, A. Weissbach (Lübeck, Germany)
Functional network correlates of APOE ε4 allele in Parkinson’s disease

K. Schindlbeck, A. Vo, P. Mattis, N. Nguyen, D. Eidelberg (Munich, Germany)
Functional Neuroimaging and Follow up trends in Drug induced movement disorders.

V. Mathur, A. Shetty, H. Shah, V. Lele, P. Wadia (Jaipur, India)